Phillips, K.A.; Stein, D.J.; Rauch, S.L.; Hollander, E.; Fallon, B.A.; Barsky, A.; Fineberg, N.; Mataix-Cols, D.; Ferrão, Y.A.; Saxena, S.; Wilhelm, S.; Kelly, M.M.; Clark, L.A.; Pinto, A.; Bienvenu, O.J.; Farrow, J.; Leckman, J. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress. Anxiety, 2010, 27(6), 528-555.
[http://dx.doi.org/10.1002/da.20705] [PMID: 20533367]

Stein, D.J.; Kogan, C.S.; Atmaca, M.; Fineberg, N.A.; Fontenelle, L.F.; Grant, J.E.; Matsunaga, H.; Reddy, Y.C.J.; Simpson, H.B.; Thomsen, P.H.; van den Heuvel, O.A.; Veale, D.; Woods, D.W.; Reed, G.M. The classification of obsessive-compulsive and related disorders in the ICD-11. J. Affect. Disord., 2016, 190, 663-674.
[http://dx.doi.org/10.1016/j.jad.2015.10.061] [PMID: 26590514]

Stein, D.J.; Craske, M.G.; Friedman, M.J.; Phillips, K.A. Meta-structure issues for the DSM-5: how do anxiety disorders, obsessive-compulsive and related disorders, post-traumatic disorders, and dissociative disorders fit together? Curr. Psychiatry Rep., 2011, 13(4), 248-250.
[http://dx.doi.org/10.1007/s11920-011-0207-1] [PMID: 21603904]

Ruscio, A.M.; Stein, D.J.; Chiu, W.T.; Kessler, R.C. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol. Psychiatry, 2010, 15(1), 53-63.
[http://dx.doi.org/10.1038/mp.2008.94] [PMID: 18725912]

Fontenelle, L.F.; Mendlowicz, M.V.; Versiani, M. The descriptive epidemiology of obsessive–compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30(3), 327-337.
[http://dx.doi.org/10.1016/j.pnpbp.2005.11.001] [PMID: 16412548]

Fawcett, E.J.; Power, H.; Fawcett, J.M. Women are at greater risk of OCD than men. J. Clin. Psychiatry, 2020, 81(4), 19r13085.
[http://dx.doi.org/10.4088/JCP.19r13085] [PMID: 32603559]

Murray, C.J.L.; Lopez, A.D. Evidence-based health policy--lessons from the Global Burden of Disease Study. Science, 1996, 274(5288), 740-743.
[http://dx.doi.org/10.1126/science.274.5288.740] [PMID: 8966556]

World Health Organization. Depression and other common mental disorders: global health estimates; World Health Organization, 2017.

World Health Organization. The global burden of disease  2004 update; World Health Organization, 2008, p. 146p.

Simpson, H.B.; Huppert, J.D.; Petkova, E.; Foa, E.B.; Liebowitz, M.R. Response versus remission in obsessive-compulsive disorder. J. Clin. Psychiatry, 2006, 67(2), 269-276.
[http://dx.doi.org/10.4088/JCP.v67n0214] [PMID: 16566623]

Pallanti, S.; Quercioli, L. Treatment-refractory obsessive-compulsive disorder: Methodological issues, operational definitions and therapeutic lines. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30(3), 400-412.
[http://dx.doi.org/10.1016/j.pnpbp.2005.11.028] [PMID: 16503369]

Greist, J.H.; Bandelow, B.; Hollander, E.; Marazziti, D.; Montgomery, S.A.; Nutt, D.J.; Okasha, A.; Swinson, R.P.; Zohar, J. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr., 2003, 8(S1), 7-16.
[http://dx.doi.org/10.1017/S1092852900006908] [PMID: 14767394]

Middleton, R.; Wheaton, M.G.; Kayser, R.S.H. Treatment resistance in obsessive-compulsive disorder. In: Treatment Resistance in Psychiatry; Yk, K., Ed.; Springer Singapore: Singapore, 2019.
[http://dx.doi.org/10.1007/978-981-10-4358-1_11]

Simpson, H.B.; Hezel, D.M. Exposure and response prevention for obsessive-compulsive disorder: A review and new directions. Indian J. Psychiatry, 2019, 61(7)(Suppl. 1), 85.
[http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_516_18] [PMID: 30745681]

Wolmarans, D.W.; Scheepers, I.M.; Stein, D.J.; Harvey, B.H. Peromyscus maniculatus bairdii as a naturalistic mammalian model of obsessive-compulsive disorder: current status and future challenges. Metab. Brain Dis., 2018, 33(2), 443-455.
[http://dx.doi.org/10.1007/s11011-017-0161-7] [PMID: 29214602]

Szechtman, H; Ahmari, SE; Beninger, RJ; Eilam, D; Harvey, BH; Edemann-Callesen, H Obsessive-compulsive disorder: Insights from animal models. Neurosci Biobehav Rev, 2017, 76(Pt B), 254-79.

Ahmari, S.E.; Spellman, T.; Douglass, N.L.; Kheirbek, M.A.; Simpson, H.B.; Deisseroth, K.; Gordon, J.A.; Hen, R. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science, 2013, 340(6137), 1234-1239.
[http://dx.doi.org/10.1126/science.1234733] [PMID: 23744948]

Andersen, S.L.; Greene-Colozzi, E.A.; Sonntag, K.C. A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals. Biol. Psychiatry, 2010, 68(8), 741-747.
[http://dx.doi.org/10.1016/j.biopsych.2010.05.011] [PMID: 20619828]

Burguière, E.; Monteiro, P.; Feng, G.; Graybiel, A.M. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science, 2013, 340(6137), 1243-1246.
[http://dx.doi.org/10.1126/science.1232380] [PMID: 23744950]

Camilla d’Angelo, L.S.; Eagle, D.M.; Grant, J.E.; Fineberg, N.A.; Robbins, T.W.; Chamberlain, S.R. Animal models of obsessive-compulsive spectrum disorders. CNS Spectr., 2014, 19(1), 28-49.
[http://dx.doi.org/10.1017/S1092852913000564] [PMID: 24093759]

Joel, D.; Klavir, O. The effects of temporary inactivation of the orbital cortex in the signal attenuation rat model of obsessive compulsive disorder. Behav. Neurosci., 2006, 120(4), 976-983.
[http://dx.doi.org/10.1037/0735-7044.120.4.976] [PMID: 16893303]

Korff, S.; Stein, D.J.; Harvey, B.H. Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(2), 348-355.
[http://dx.doi.org/10.1016/j.pnpbp.2007.08.032] [PMID: 17888556]

Shmelkov, S.V.; Hormigo, A.; Jing, D.; Proenca, C.C.; Bath, K.G.; Milde, T.; Shmelkov, E.; Kushner, J.S.; Baljevic, M.; Dincheva, I.; Murphy, A.J.; Valenzuela, D.M.; Gale, N.W.; Yancopoulos, G.D.; Ninan, I.; Lee, F.S.; Rafii, S. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice. Nat. Med., 2010, 16(5), 598-602.
[http://dx.doi.org/10.1038/nm.2125] [PMID: 20418887]

Welch, J.M.; Lu, J.; Rodriguiz, R.M.; Trotta, N.C.; Peca, J.; Ding, J.D.; Feliciano, C.; Chen, M.; Adams, J.P.; Luo, J.; Dudek, S.M.; Weinberg, R.J.; Calakos, N.; Wetsel, W.C.; Feng, G. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature, 2007, 448(7156), 894-900.
[http://dx.doi.org/10.1038/nature06104] [PMID: 17713528]

Wood, J.; LaPalombara, Z.; Ahmari, S.E. Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2018, 373(1742), 20170023.
[http://dx.doi.org/10.1098/rstb.2017.0023] [PMID: 29352023]

Ahmari, S.E. Using mice to model Obsessive Compulsive Disorder: From genes to circuits. Neuroscience, 2016, 321, 121-137.
[http://dx.doi.org/10.1016/j.neuroscience.2015.11.009] [PMID: 26562431]

Chamberlain, B.L.; Ahmari, S.E. Animal Models for OCD Research. In: Current Topics in Behavioral Neurosciences; Fineberg, N.A.; Robbins, T.W., Eds.; Springer International Publishing: Cham, 2021; pp. 55-96. [Internet]

Fernandez, T.V.; Leckman, J.F.; Pittenger, C. Genetic susceptibility in obsessive-compulsive disorder. Handb. Clin. Neurol., 2018, 148, 767-781.
[http://dx.doi.org/10.1016/B978-0-444-64076-5.00049-1] [PMID: 29478613]

Mataix-Cols, D.; Boman, M.; Monzani, B.; Rück, C.; Serlachius, E.; Långström, N.; Lichtenstein, P. Population-based, multigenerational family clustering study of obsessive-compulsive disorder. JAMA Psychiatry, 2013, 70(7), 709-717.
[http://dx.doi.org/10.1001/jamapsychiatry.2013.3] [PMID: 23699935]

Brander, G.; Kuja-Halkola, R.; Rosenqvist, M.A.; Rück, C.; Serlachius, E.; Fernández de la Cruz, L.; Lichtenstein, P.; Crowley, J.J.; Larsson, H.; Mataix-Cols, D. A population-based family clustering study of tic-related obsessive-compulsive disorder. Mol. Psychiatry, 2021, 26(4), 1224-1233.
[http://dx.doi.org/10.1038/s41380-019-0532-z] [PMID: 31616041]

Pauls, D.L.; Abramovitch, A.; Rauch, S.L.; Geller, D.A. Obsessive–compulsive disorder: an integrative genetic and neurobiological perspective. Nat. Rev. Neurosci., 2014, 15(6), 410-424.
[http://dx.doi.org/10.1038/nrn3746] [PMID: 24840803]

Chakrabarty, K.; Bhattacharyya, S.; Christopher, R.; Khanna, S. Glutamatergic dysfunction in OCD. Neuropsychopharmacology, 2005, 30(9), 1735-1740.

Kariuki-Nyuthe, C.; Gomez-Mancilla, B.; Stein, D.J. Obsessive compulsive disorder and the glutamatergic system. Curr. Opin. Psychiatry, 2014, 27(1), 32-37.
[http://dx.doi.org/10.1097/YCO.0000000000000017] [PMID: 24270485]

Wu, K.; Hanna, G.L.; Rosenberg, D.R.; Arnold, P.D. The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder. Pharmacol. Biochem. Behav., 2012, 100(4), 726-735.
[http://dx.doi.org/10.1016/j.pbb.2011.10.007] [PMID: 22024159]

Wu, K.; Hanna, G.L.; Easter, P.; Kennedy, J.L.; Rosenberg, D.R.; Arnold, P.D. Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: A preliminary study. Psychiatry Res. Neuroimaging, 2013, 211(3), 214-220.
[http://dx.doi.org/10.1016/j.pscychresns.2012.07.003] [PMID: 23154099]

Arnold, P.D.; Askland, K.D.; Barlassina, C.; Bellodi, L.; Bienvenu, O.J.; Black, D. Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis. Mol. Psychiatry, 2018, 23(5), 1181-1188.
[http://dx.doi.org/10.1038/mp.2017.154] [PMID: 28761083]

Mahjani, B.; Bey, K.; Boberg, J.; Burton, C. Genetics of obsessive-compulsive disorder. Psychol. Med., 2021, 51(13), 2247-2259.
[http://dx.doi.org/10.1017/S0033291721001744] [PMID: 34030745]

Pauls, D.L. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin. Neurosci., 2010, 12(2), 149-163.
[http://dx.doi.org/10.31887/DCNS.2010.12.2/dpauls] [PMID: 20623920]

Mataix-Cols, D.; Wooderson, S.; Lawrence, N.; Brammer, M.J.; Speckens, A.; Phillips, M.L. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2004, 61(6), 564-576.
[http://dx.doi.org/10.1001/archpsyc.61.6.564] [PMID: 15184236]

Bandelow, B.; Baldwin, D.; Abelli, M.; Bolea-Alamanac, B.; Bourin, M.; Chamberlain, S.R. Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World J. Biol. Psychiatry, 2017, 18(3), 162-214.

Bhattacharyya, S.; Khanna, S.; Chakrabarty, K.; Mahadevan, A.; Christopher, R.; Shankar, S.K. Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Neuropsychopharmacology, 2009, 34(12), 2489-2496.

Guo, H.R.; Huang, B.L.; Wang, Y.L.; Zhang, Y.Y.; Ma, Q.G.; Lv, P.P.; Ren, Y.M. Effect of escitalopram on serum GDNF and BDNF levels and 5-HT level of brain tissue of obsessive-compulsive disorder rats. Cell. Mol. Neurobiol., 2020, 40(6), 991-997.
[http://dx.doi.org/10.1007/s10571-020-00788-4] [PMID: 31927718]

Lustberg, D.; Iannitelli, A.F.; Tillage, R.P.; Pruitt, M.; Liles, L.C.; Weinshenker, D. Central norepinephrine transmission is required for stress-induced repetitive behavior in two rodent models of obsessive-compulsive disorder. Psychopharmacology (Berl.), 2020, 237(7), 1973-1987.
[http://dx.doi.org/10.1007/s00213-020-05512-0] [PMID: 32313981]

Stein, D.J.; Costa, D.L.C.; Lochner, C.; Miguel, E.C.; Reddy, Y.C.J.; Shavitt, R.G.; van den Heuvel, O.A.; Simpson, H.B. Obsessive-compulsive disorder. Nat. Rev. Dis. Primers, 2019, 5(1), 52.
[http://dx.doi.org/10.1038/s41572-019-0102-3] [PMID: 31371720]

van den Heuvel, O.A.; van Wingen, G.; Soriano-Mas, C.; Alonso, P.; Chamberlain, S.R.; Nakamae, T. Brain circuitry of compulsivity. Eur. Neuropsychopharmacol., 2016, 26(5), 810-827.

Kwon, J.S.; Jang, J.H.; Choi, J.S.; Kang, D.H. Neuroimaging in obsessive–compulsive disorder. Expert Rev. Neurother., 2009, 9(2), 255-269.
[http://dx.doi.org/10.1586/14737175.9.2.255] [PMID: 19210199]

Baxter, L.R., Jr; Schwartz, J.M.; Bergman, K.S.; Szuba, M.P.; Guze, B.H.; Mazziotta, J.C.; Alazraki, A.; Selin, C.E.; Ferng, H.K.; Munford, P. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch. Gen. Psychiatry, 1992, 49(9), 681-689.
[http://dx.doi.org/10.1001/archpsyc.1992.01820090009002] [PMID: 1514872]

Chamberlain, S.R.; Menzies, L.; Hampshire, A.; Suckling, J.; Fineberg, N.A.; del Campo, N.; Aitken, M.; Craig, K.; Owen, A.M.; Bullmore, E.T.; Robbins, T.W.; Sahakian, B.J. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science, 2008, 321(5887), 421-422.
[http://dx.doi.org/10.1126/science.1154433] [PMID: 18635808]

Maia, T.V.; Cooney, R.E.; Peterson, B.S. The neural bases of obsessive–compulsive disorder in children and adults. Dev. Psychopathol., 2008, 20(4), 1251-1283.
[http://dx.doi.org/10.1017/S0954579408000606] [PMID: 18838041]

Pujol, J.; Soriano-Mas, C.; Alonso, P.; Cardoner, N.; Menchón, J.M.; Deus, J.; Vallejo, J. Mapping structural brain alterations in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2004, 61(7), 720-730.
[http://dx.doi.org/10.1001/archpsyc.61.7.720] [PMID: 15237084]

Saxena, S.; Bota, R.G.; Brody, A.L. Brain-behavior relationships in obsessive-compulsive disorder. Semin. Clin. Neuropsychiatry, 2001, 6(2), 82-101.
[http://dx.doi.org/10.1053/scnp.2001.21833] [PMID: 11296309]

Saxena, S.; Brody, A.L.; Schwartz, J.M.; Baxter, L.R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br. J. Psychiatry, 1998, 173(S35), 26-37.
[http://dx.doi.org/10.1192/S0007125000297870] [PMID: 9829024]

Saxena, S.; Rauch, S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr. Clin. North Am., 2000, 23(3), 563-586.
[http://dx.doi.org/10.1016/S0193-953X(05)70181-7] [PMID: 10986728]

van den Heuvel, O.A.; Veltman, D.J.; Groenewegen, H.J.; Cath, D.C.; van Balkom, A.J.L.M.; van Hartskamp, J.; Barkhof, F.; van Dyck, R. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2005, 62(3), 301-309.
[http://dx.doi.org/10.1001/archpsyc.62.3.301] [PMID: 15753243]

Heuvel, O.A.; Boedhoe, P.S.W.; Bertolin, S.; Bruin, W.B.; Francks, C.; Ivanov, I.; Jahanshad, N.; Kong, X.Z.; Kwon, J.S.; O’Neill, J.; Paus, T.; Patel, Y.; Piras, F.; Schmaal, L.; Soriano-Mas, C.; Spalletta, G.; Wingen, G.A.; Yun, J.Y.; Vriend, C.; Simpson, H.B.; Rooij, D.; Hoexter, M.Q.; Hoogman, M.; Buitelaar, J.K.; Arnold, P.; Beucke, J.C.; Benedetti, F.; Bollettini, I.; Bose, A.; Brennan, B.P.; De Nadai, A.S.; Fitzgerald, K.; Gruner, P.; Grünblatt, E.; Hirano, Y.; Huyser, C.; James, A.; Koch, K.; Kvale, G.; Lazaro, L.; Lochner, C.; Marsh, R.; Mataix-Cols, D.; Morgado, P.; Nakamae, T.; Nakao, T.; Narayanaswamy, J.C.; Nurmi, E.; Pittenger, C.; Reddy, Y.C.J.; Sato, J.R.; Soreni, N.; Stewart, S.E.; Taylor, S.F.; Tolin, D.; Thomopoulos, S.I.; Veltman, D.J.; Venkatasubramanian, G.; Walitza, S.; Wang, Z.; Thompson, P.M.; Stein, D.J.; Abe, Y.; Alonso, P.; Assogna, F.; Banaj, N.; Batistuzzo, M.C.; Brem, S.; Ciullo, V.; Feusner, J.; Martínez-Zalacaín, I.; Menchón, J.M.; Miguel, E.C.; Piacentini, J.; Piras, F.; Sakai, Y.; Wolters, L.; Yamada, K. An overview of the first 5 years of the ENIGMA obsessive–compulsive disorder working group: The power of worldwide collaboration. Hum. Brain Mapp., 2022, 43(1), 23-36.
[http://dx.doi.org/10.1002/hbm.24972] [PMID: 32154629]

Bu, X.; Hu, X.; Zhang, L.; Li, B.; Zhou, M.; Lu, L.; Hu, X.; Li, H.; Yang, Y.; Tang, W.; Gong, Q.; Huang, X. Investigating the predictive value of different resting-state functional MRI parameters in obsessive-compulsive disorder. Transl. Psychiatry, 2019, 9(1), 17.
[http://dx.doi.org/10.1038/s41398-018-0362-9] [PMID: 30655506]

Narayanaswamy, J.C.; Hazari, N.; Venkatasubramanian, G. Neuroimaging findings in obsessive–compulsive disorder: A narrative review to elucidate neurobiological underpinnings. Indian J. Psychiatry, 2019, 61(7)(Suppl. 1), 9.
[http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_525_18] [PMID: 30745673]

Tian, L.; Meng, C.; Jiang, Y.; Tang, Q.; Wang, S.; Xie, X.; Fu, X.; Jin, C.; Zhang, F.; Wang, J. Abnormal functional connectivity of brain network hubs associated with symptom severity in treatment-naive patients with obsessive–compulsive disorder: A resting-state functional MRI study. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2016, 66, 104-111.
[http://dx.doi.org/10.1016/j.pnpbp.2015.12.003] [PMID: 26683173]

Gürsel, D.A.; Avram, M.; Sorg, C.; Brandl, F.; Koch, K. Frontoparietal areas link impairments of large-scale intrinsic brain networks with aberrant fronto-striatal interactions in OCD: a meta-analysis of resting-state functional connectivity. Neurosci. Biobehav. Rev., 2018, 87, 151-160.
[http://dx.doi.org/10.1016/j.neubiorev.2018.01.016] [PMID: 29410103]

Gonçalves, Ó.F.; Soares, J.M.; Carvalho, S.; Leite, J.; Ganho-Ávila, A.; Fernandes-Gonçalves, A.; Pocinho, F.; Carracedo, A.; Sampaio, A. Patterns of default mode network deactivation in obsessive compulsive disorder. Sci. Rep., 2017, 7(1), 44468.
[http://dx.doi.org/10.1038/srep44468] [PMID: 28287615]

Stern, E.R.; Fitzgerald, K.D.; Welsh, R.C.; Abelson, J.L.; Taylor, S.F. Resting-state functional connectivity between fronto-parietal and default mode networks in obsessive-compulsive disorder. PLoS One, 2012, 7(5), e36356.
[http://dx.doi.org/10.1371/journal.pone.0036356] [PMID: 22570705]

Hansen, E.S.; Hasselbalch, S.; Law, I.; Bolwig, T.G. The caudate nucleus in obsessive–compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int. J. Neuropsychopharmacol., 2002, 5(1), 1-10.
[http://dx.doi.org/10.1017/S1461145701002681] [PMID: 12057027]

Perani, D.; Colombo, C.; Bressi, S.; Bonfanti, A.; Grassi, F.; Scarone, S.; Bellodi, L.; Smeraldi, E.; Fazio, F. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br. J. Psychiatry, 1995, 166(2), 244-250.
[http://dx.doi.org/10.1192/bjp.166.2.244] [PMID: 7728370]

Saxena, S.; Brody, A.L.; Maidment, K.M.; Dunkin, J.J.; Colgan, M.; Alborzian, S. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology, 1999, 21(6), 683-693.

Gerentes, M.; Pelissolo, A.; Rajagopal, K.; Tamouza, R.; Hamdani, N. Obsessive-compulsive disorder. Autoimmunity and Neuroinflammation. Curr. Psychiatry Rep., 2019, 21(8), 78.
[http://dx.doi.org/10.1007/s11920-019-1062-8] [PMID: 31367805]

Attwells, S.; Setiawan, E.; Wilson, A.A.; Rusjan, P.M.; Mizrahi, R.; Miler, L.; Xu, C.; Richter, M.A.; Kahn, A.; Kish, S.J.; Houle, S.; Ravindran, L.; Meyer, J.H. Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiatry, 2017, 74(8), 833-840.
[http://dx.doi.org/10.1001/jamapsychiatry.2017.1567] [PMID: 28636705]

Turna, J.; Grosman Kaplan, K.; Anglin, R.; Van Ameringen, M. “What’s bugging the gut in OCD?” A review of the gut microbiome in obsessive-compulsive disorder. Depress. Anxiety, 2016, 33(3), 171-178.
[http://dx.doi.org/10.1002/da.22454] [PMID: 26629974]

Renna, M.E.; O’Toole, M.S.; Spaeth, P.E.; Lekander, M.; Mennin, D.S. The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: A systematic review and meta-analysis. Depress. Anxiety, 2018, 35(11), 1081-1094.
[http://dx.doi.org/10.1002/da.22790] [PMID: 30199144]

Lewis, D.A. The human brain revisited: Opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology, 2002, 26(2), 143-154.

de Lange, G.M. Understanding the cellular and molecular alterations in PTSD brains: The necessity of post-mortem brain tissue. Eur. J. Psychotraumatol., 2017, 8(1), 1341824.
[http://dx.doi.org/10.1080/20008198.2017.1341824] [PMID: 28680541]

Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; Chou, R.; Glanville, J.; Grimshaw, J.M.; Hróbjartsson, A.; Lalu, M.M.; Li, T.; Loder, E.W.; Mayo-Wilson, E.; McDonald, S.; McGuinness, L.A.; Stewart, L.A.; Thomas, J.; Tricco, A.C.; Welch, V.A.; Whiting, P.; Moher, D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021, 372(71), n71.
[http://dx.doi.org/10.1136/bmj.n71] [PMID: 33782057]

Downes, M.J.; Brennan, M.L.; Williams, H.C.; Dean, R.S. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open, 2016, 6(12), e011458.
[http://dx.doi.org/10.1136/bmjopen-2016-011458] [PMID: 27932337]

Jaffe, A.E.; Deep-Soboslay, A.; Tao, R.; Hauptman, D.T.; Kaye, W.H.; Arango, V.; Weinberger, D.R.; Hyde, T.M.; Kleinman, J.E. Genetic neuropathology of obsessive psychiatric syndromes. Transl. Psychiatry, 2014, 4(9), e432.
[http://dx.doi.org/10.1038/tp.2014.68] [PMID: 25180571]

Lipska, B.K.; Deep-Soboslay, A.; Weickert, C.S.; Hyde, T.M.; Martin, C.E.; Herman, M.M.; Kleinman, J.E. Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia. Biol. Psychiatry, 2006, 60(6), 650-658.
[http://dx.doi.org/10.1016/j.biopsych.2006.06.019] [PMID: 16997002]

Ruden, J.B.; Dugan, L.L.; Konradi, C. Parvalbumin interneuron vulnerability and brain disorders. Neuropsychopharmacology, 2021, 46(2), 279-287.
[http://dx.doi.org/10.1038/s41386-020-0778-9]

Hoseth, E.Z.; Krull, F.; Dieset, I.; Mørch, R.H.; Hope, S.; Gardsjord, E.S.; Steen, N.E.; Melle, I.; Brattbakk, H.R.; Steen, V.M.; Aukrust, P.; Djurovic, S.; Andreassen, O.A.; Ueland, T. Attenuated Notch signaling in schizophrenia and bipolar disorder. Sci. Rep., 2018, 8(1), 5349.
[http://dx.doi.org/10.1038/s41598-018-23703-w] [PMID: 29593239]

de Oliveira, K.C.; Grinberg, L.T.; Hoexter, M.Q.; Brentani, H.; Suemoto, C.K.; Nery, F.G.; Lima, L.C.; Alho, A.T.D.L.; Farfel, J.M.; Ferretti-Rebustini, R.E.L.; Leite, R.E.P.; Moretto, A.C.; da Silva, A.V.; Lafer, B.; Miguel, E.C.; Nitrini, R.; Jacob-Filho, W.; Heinsen, H.; Pasqualucci, C.A. Layer-specific reduced neuronal density in the orbitofrontal cortex of older adults with obsessive–compulsive disorder. Brain Struct. Funct., 2019, 224(1), 191-203.
[http://dx.doi.org/10.1007/s00429-018-1752-8] [PMID: 30298291]

Hoexter, M.Q.; Diniz, J.B.; Lopes, A.C.; Batistuzzo, M.C.; Shavitt, R.G.; Dougherty, D.D.; Duran, F.L.S.; Bressan, R.A.; Busatto, G.F.; Miguel, E.C.; Sato, J.R. Orbitofrontal thickness as a neasure for treatment response prediction in obsessive-compulsive disorder. Depress. Anxiety, 2015, 32(12), 900-908.
[http://dx.doi.org/10.1002/da.22380] [PMID: 26032588]

Christian, C.J.; Lencz, T.; Robinson, D.G.; Burdick, K.E.; Ashtari, M.; Malhotra, A.K.; Betensky, J.D.; Szeszko, P.R. Gray matter structural alterations in obsessive–compulsive disorder: Relationship to neuropsychological functions. Psychiatry Res. Neuroimaging, 2008, 164(2), 123-131.
[http://dx.doi.org/10.1016/j.pscychresns.2008.03.005] [PMID: 18938065]

Kim, J.J.; Lee, M.C.; Kim, J.; Kim, I.Y.; Kim, S.I.; Han, M.H.; Chang, K.H.; Kwon, J.S. Grey matter abnormalities in obsessive–compulsive disorder. Br. J. Psychiatry, 2001, 179(4), 330-334.
[http://dx.doi.org/10.1192/bjp.179.4.330] [PMID: 11581113]

Valente, A.A., Jr; Miguel, E.C.; Castro, C.C.; Amaro, E., Jr; Duran, F.L.S.; Buchpiguel, C.A.; Chitnis, X.; McGuire, P.K.; Busatto, G.F. Regional gray matter abnormalities in obsessive-compulsive disorder: A voxel-based morphometry study. Biol. Psychiatry, 2005, 58(6), 479-487.
[http://dx.doi.org/10.1016/j.biopsych.2005.04.021] [PMID: 15978549]

Hoexter, M.Q.; de Souza Duran, F.L.; D’Alcante, C.C.; Dougherty, D.D.; Shavitt, R.G.; Lopes, A.C. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: A randomized clinical trial. Neuropsychopharmacology, 2012, 37(3), 45.

Rotge, J-Y.; Langbour, N.; Guehl, D.; Bioulac, B.; Jaafari, N.; Allard, M. Gray matter alterations in obsessive-compulsive disorder: An anatomic likelihood estimation meta-analysis. Neuropsychopharmacology, 2010, 35(3), 686-691.

Szeszko, P.R.; Robinson, D.; Alvir, J.M.J.; Bilder, R.M.; Lencz, T.; Ashtari, M.; Wu, H.; Bogerts, B. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 1999, 56(10), 913-919.
[http://dx.doi.org/10.1001/archpsyc.56.10.913] [PMID: 10530633]

Togao, O.; Yoshiura, T.; Nakao, T.; Nabeyama, M.; Sanematsu, H.; Nakagawa, A.; Noguchi, T.; Hiwatashi, A.; Yamashita, K.; Nagao, E.; Kanba, S.; Honda, H. Regional gray and white matter volume abnormalities in obsessive–compulsive disorder: A voxel-based morphometry study. Psychiatry Res. Neuroimaging, 2010, 184(1), 29-37.
[http://dx.doi.org/10.1016/j.pscychresns.2010.06.011] [PMID: 20833001]

Yoo, S.Y.; Roh, M.S.; Choi, J.S.; Kang, D.H.; Ha, T.H.; Lee, J.M.; Kim, I.Y.; Kim, S.I.; Kwon, J.S. Voxel-based morphometry study of gray matter abnormalities in obsessive-compulsive disorder. J. Korean Med. Sci., 2008, 23(1), 24-30.
[http://dx.doi.org/10.3346/jkms.2008.23.1.24] [PMID: 18303194]

Gillan, C.M.; Apergis-Schoute, A.M.; Morein-Zamir, S.; Urcelay, G.P.; Sule, A.; Fineberg, N.A.; Sahakian, B.J.; Robbins, T.W. Functional neuroimaging of avoidance habits in obsessive-compulsive disorder. Am. J. Psychiatry, 2015, 172(3), 284-293.
[http://dx.doi.org/10.1176/appi.ajp.2014.14040525] [PMID: 25526600]

Harrison, B.J.; Pujol, J.; Soriano-Mas, C.; Hernández-Ribas, R.; López-Solà, M.; Ortiz, H.; Alonso, P.; Deus, J.; Menchon, J.M.; Real, E.; Segalàs, C.; Contreras-Rodríguez, O.; Blanco-Hinojo, L.; Cardoner, N. Neural correlates of moral sensitivity in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2012, 69(7), 741-749.
[http://dx.doi.org/10.1001/archgenpsychiatry.2011.2165] [PMID: 22752238]

Maltby, N.; Tolin, D.F.; Worhunsky, P.; O’Keefe, T.M.; Kiehl, K.A. Dysfunctional action monitoring hyperactivates frontal–striatal circuits in obsessive–compulsive disorder: an event-related fMRI study. Neuroimage, 2005, 24(2), 495-503.
[http://dx.doi.org/10.1016/j.neuroimage.2004.08.041] [PMID: 15627591]

Radua, J.; Mataix-Cols, D. Voxel-wise meta-analysis of grey matter changes in obsessive–compulsive disorder. Br. J. Psychiatry, 2009, 195(5), 393-402.
[http://dx.doi.org/10.1192/bjp.bp.108.055046] [PMID: 19880927]

Lisboa, B.C.G.; Oliveira, K.C.; Tahira, A.C.; Barbosa, A.R.; Feltrin, A.S.A.; Gouveia, G.; Lima, L.; Feio dos Santos, A.C.; Martins, D.C., Jr; Puga, R.D.; Moretto, A.C.; De Bragança Pereira, C.A.; Lafer, B.; Leite, R.E.P.; Ferretti-Rebustini, R.E.D.L.; Farfel, J.M.; Grinberg, L.T.; Jacob-Filho, W.; Miguel, E.C.; Hoexter, M.Q.; Brentani, H. Initial findings of striatum tripartite model in OCD brain samples based on transcriptome analysis. Sci. Rep., 2019, 9(1), 3086.
[http://dx.doi.org/10.1038/s41598-019-38965-1] [PMID: 30816141]

Milad, M.R.; Pitman, R.K.; Ellis, C.B.; Gold, A.L.; Shin, L.M.; Lasko, N.B.; Zeidan, M.A.; Handwerger, K.; Orr, S.P.; Rauch, S.L. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol. Psychiatry, 2009, 66(12), 1075-1082.
[http://dx.doi.org/10.1016/j.biopsych.2009.06.026] [PMID: 19748076]

Milad, M.R.; Rauch, S.L. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn. Sci., 2012, 16(1), 43-51.
[http://dx.doi.org/10.1016/j.tics.2011.11.003] [PMID: 22138231]

Tschernegg, M.; Pletzer, B.; Schwartenbeck, P.; Ludersdorfer, P.; Hoffmann, U.; Kronbichler, M. Impulsivity relates to striatal gray matter volumes in humans: evidence from a delay discounting paradigm. Front. Hum. Neurosci., 2015, 9, 384.
[http://dx.doi.org/10.3389/fnhum.2015.00384] [PMID: 26190993]

Piras, F.; Piras, F.; Chiapponi, C.; Girardi, P.; Caltagirone, C.; Spalletta, G. Widespread structural brain changes in OCD: A systematic review of voxel-based morphometry studies. Cortex, 2015, 62, 89-108.
[http://dx.doi.org/10.1016/j.cortex.2013.01.016] [PMID: 23582297]

Parkes, L.; Fulcher, B.D.; Yücel, M.; Fornito, A. Transcriptional signatures of connectomic subregions of the human striatum. Genes Brain Behav., 2017, 16(7), 647-663.
[http://dx.doi.org/10.1111/gbb.12386] [PMID: 28421658]

de Oliveira, K.C.; Camilo, C.; Gastaldi, V.D.; Sant’Anna Feltrin, A.; Lisboa, B.C.G.; de Jesus Rodrigues de Paula, V. Brain areas involved with obsessive-compulsive disorder present different DNA methylation modulation. BMC genomic data, 2021, 22(1), 45.

Yue, W.; Cheng, W.; Liu, Z.; Tang, Y.; Lu, T.; Zhang, D.; Tang, M.; Huang, Y. Genome-wide DNA methylation analysis in obsessive-compulsive disorder patients. Sci. Rep., 2016, 6(1), 31333.
[http://dx.doi.org/10.1038/srep31333] [PMID: 27527274]

Nissen, J.B.; Hansen, C.S.; Starnawska, A.; Mattheisen, M.; Børglum, A.D.; Buttenschøn, H.N.; Hollegaard, M. DNA Methylation at the neonatal state and at the time of diagnosis: Preliminary support for an association with the estrogen receptor 1, gamma-aminobutyric acid B receptor 1, and myelin oligodendrocyte glycoprotein in female adolescent patients with OCD. Front. Psychiatry, 2016, 7, 35.
[http://dx.doi.org/10.3389/fpsyt.2016.00035] [PMID: 27047397]

Cappi, C.; Diniz, J.B.; Requena, G.L.; Lourenço, T.; Lisboa, B.C.G.; Batistuzzo, M.C.; Marques, A.H.; Hoexter, M.Q.; Pereira, C.A.; Miguel, E.C.; Brentani, H. Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive–compulsive disorder. BMC Neurosci., 2016, 17(1), 79.
[http://dx.doi.org/10.1186/s12868-016-0313-4] [PMID: 27903255]

D’Addario, C.; Bellia, F.; Benatti, B.; Grancini, B.; Vismara, M.; Pucci, M.; De Carlo, V.; Viganò, C.; Galimberti, D.; Fenoglio, C.; Scarpini, E.; Maccarrone, M.; Dell’Osso, B. Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder. J. Psychiatr. Res., 2019, 114, 17-23.
[http://dx.doi.org/10.1016/j.jpsychires.2019.04.006] [PMID: 31004918]

Grünblatt, E.; Marinova, Z.; Roth, A.; Gardini, E.; Ball, J.; Geissler, J.; Wojdacz, T.K.; Romanos, M.; Walitza, S. Combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder. J. Psychiatr. Res., 2018, 96, 209-217.
[http://dx.doi.org/10.1016/j.jpsychires.2017.10.010] [PMID: 29102815]

Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol., 2013, 14(10), R115.
[http://dx.doi.org/10.1186/gb-2013-14-10-r115] [PMID: 24138928]

Marazziti, D.; Mucci, F.; Fontenelle, L.F. Immune system and obsessive-compulsive disorder. Psychoneuroendocrinology, 2018, 93, 39-44.
[http://dx.doi.org/10.1016/j.psyneuen.2018.04.013] [PMID: 29689421]

Rodriguez, N.; Morer, A.; González-Navarro, E.A.; Gassó, P.; Boloc, D.; Serra-Pagès, C. Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder. World J. Biol. Psychiatry, 2019, 20(5), 352-358.

Piantadosi, S.C.; Chamberlain, B.L.; Glausier, J.R.; Lewis, D.A.; Ahmari, S.E. Lower excitatory synaptic gene expression in orbitofrontal cortex and striatum in an initial study of subjects with obsessive compulsive disorder. Mol. Psychiatry, 2021, 26(3), 986-998.
[http://dx.doi.org/10.1038/s41380-019-0431-3] [PMID: 31168067]

Harrison, B.J.; Soriano-Mas, C.; Pujol, J.; Ortiz, H.; López-Solà, M.; Hernández-Ribas, R.; Deus, J.; Alonso, P.; Yücel, M.; Pantelis, C.; Menchon, J.M.; Cardoner, N. Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch. Gen. Psychiatry, 2009, 66(11), 1189-1200.
[http://dx.doi.org/10.1001/archgenpsychiatry.2009.152] [PMID: 19884607]

Menzies, L.; Achard, S.; Chamberlain, S.R.; Fineberg, N.; Chen, C.H.; del Campo, N.; Sahakian, B.J.; Robbins, T.W.; Bullmore, E. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain, 2007, 130(12), 3223-3236.
[http://dx.doi.org/10.1093/brain/awm205] [PMID: 17855376]

Menzies, L.; Chamberlain, S.R.; Laird, A.R.; Thelen, S.M.; Sahakian, B.J.; Bullmore, E.T. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited. Neurosci. Biobehav. Rev., 2008, 32(3), 525-549.
[http://dx.doi.org/10.1016/j.neubiorev.2007.09.005] [PMID: 18061263]

Rauch, S.L.; Savage, C.R.; Alpert, N.M.; Dougherty, D.; Kendrick, A.; Curran, T.; Brown, H.D.; Manzo, P.; Fischman, A.J.; Jenike, M.A. Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J. Neuropsychiatry Clin. Neurosci., 1997, 9(4), 568-573.
[http://dx.doi.org/10.1176/jnp.9.4.568] [PMID: 9447498]

Rotge, J.Y.; Guehl, D.; Dilharreguy, B.; Tignol, J.; Bioulac, B.; Allard, M.; Burbaud, P.; Aouizerate, B. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol. Psychiatry, 2009, 65(1), 75-83.
[http://dx.doi.org/10.1016/j.biopsych.2008.06.019] [PMID: 18718575]

Piantadosi, S.C.; McClain, L.L.; Klei, L.; Wang, J.; Chamberlain, B.L.; Springer, S.A.; Lewis, D.A.; Devlin, B.; Ahmari, S.E. Transcriptome alterations are enriched for synapse-associated genes in the striatum of subjects with obsessive-compulsive disorder. Transl. Psychiatry, 2021, 11(1), 171.
[http://dx.doi.org/10.1038/s41398-021-01290-1] [PMID: 33723209]

First, M.B.; Spitzer, R.L.; Gobbon, M.; Williams, J.B.W. Structured clinical interview for DSM-IV Axis I disorders - Patient edition; New York State Psychiatric Institute, Biometrics Research Department: New York, 1998.

Goodman, W.K.; Price, L.H.; Rasmussen, S.A.; Mazure, C.; Fleischmann, R.L.; Hill, C.L.; Heninger, G.R.; Charney, D.S. The Yale-Brown obsessive-compulsive scale: I. Development, use, and reliability. Arch. Gen. Psychiatry, 1989, 46(11), 1006-1011.
[http://dx.doi.org/10.1001/archpsyc.1989.01810110048007] [PMID: 2684084]

Harrison, P.J. Using our brains: the findings, flaws, and future of postmortem studies of psychiatric disorders. Biol. Psychiatry, 2011, 69(2), 102-103.

Sidorchuk, A.; Kuja-Halkola, R.; Runeson, B.; Lichtenstein, P.; Larsson, H.; Rück, C.; D’Onofrio, B.M.; Mataix-Cols, D.; Fernández de la Cruz, L. Genetic and environmental sources of familial coaggregation of obsessive-compulsive disorder and suicidal behavior: a population-based birth cohort and family study. Mol. Psychiatry, 2021, 26(3), 974-985.
[http://dx.doi.org/10.1038/s41380-019-0417-1] [PMID: 30962511]

McCullumsmith, R.E.; Hammond, J.H.; Shan, D.; Meador-Woodruff, J.H. Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology, 2014, 39(1), 65-87.

Vidal-Ribas, P.; Stringaris, A.; Rück, C.; Serlachius, E.; Lichtenstein, P.; Mataix-Cols, D. Are stressful life events causally related to the severity of obsessive-compulsive symptoms? A monozygotic twin difference study. Eur. Psychiatry, 2015, 30(2), 309-316.

Murayama, K.; Nakao, T.; Ohno, A.; Tsuruta, S.; Tomiyama, H.; Hasuzawa, S.; Mizobe, T.; Kato, K.; Kanba, S. Impacts of stressful life events and traumatic experiences on onset of obsessive-compulsive disorder. Front. Psychiatry, 2020, 11, 561266.
[http://dx.doi.org/10.3389/fpsyt.2020.561266] [PMID: 33343411]

Rademaker, M.C.; de Lange, G.M.; Palmen, S.J.M.C. The Netherlands Brain Bank for Psychiatry. Handb. Clin. Neurol., 2018, 150, 3-16.
[http://dx.doi.org/10.1016/B978-0-444-63639-3.00001-3] [PMID: 29496148]

Ikonomovic, M.D.; Buckley, C.J.; Heurling, K.; Sherwin, P.; Jones, P.A.; Zanette, M.; Mathis, C.A.; Klunk, W.E.; Chakrabarty, A.; Ironside, J.; Ismail, A.; Smith, C.; Thal, D.R.; Beach, T.G.; Farrar, G.; Smith, A.P.L. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection. Acta Neuropathol. Commun., 2016, 4(1), 130.
[http://dx.doi.org/10.1186/s40478-016-0399-z] [PMID: 27955679]

Yendiki, A.; Aggarwal, M.; Axer, M.; Howard, A.F.D.; van Walsum, A.M.C.; Haber, S.N. Post mortem mapping of connectional anatomy for the validation of diffusion MRI. Neuroimage, 2022, 256, 119146.
[http://dx.doi.org/10.1016/j.neuroimage.2022.119146] [PMID: 35346838]

de Oliveira, K.C.; Nery, F.G.; Ferreti, R.E.L.; Lima, M.C.; Cappi, C.; Machado-Lima, A.; Polichiso, L.; Carreira, L.L.; Ávila, C.; Alho, A.T.D.L.; Brentani, H.P.; Miguel, E.C.; Heinsen, H.; Jacob-Filho, W.; Pasqualucci, C.A.; Lafer, B.; Grinberg, L.T. Brazilian psychiatric brain bank: A new contribution tool to network studies. Cell Tissue Bank., 2012, 13(2), 315-326.
[http://dx.doi.org/10.1007/s10561-011-9258-0] [PMID: 21562728]

de Lange, G.M.; Rademaker, M.; Boks, M.P.; Palmen, S.J.M.C. Brain donation in psychiatry: results of a Dutch prospective donor program among psychiatric cohort participants. BMC Psychiatry, 2017, 17(1), 347.
[http://dx.doi.org/10.1186/s12888-017-1513-x] [PMID: 29058593]